The prevalence and the risk factors of the human T-cell leukemia virus type I/II (HTLV-I/II) infection were evaluated among 552 individuals at high risk for HIV-1.
HTLV infections showed a low (1.6%) prevalence, were restricted to intravenous drug addicts and were due to HTLV-II alone.
Moreover, in order to weigh the influence of HTLV-II on the natural history of HIV-1 infection, the clinical outcome of HIV-1 disease was compared between subjects with and without HTLV-II coinfection.
Our findings showed that HTLV-II does not adversely affect the outcome of HIV-1 infection.
Infact, a slower disease progression has been recorded in some HTLV-II coinfected subjects.
Mots-clés Pascal : SIDA, Virose, Infection, Virus HIV1, Virus immunodéficience humaine, Lentivirinae, Retroviridae, Virus, Association, Virus HTLV, Epidémiologie, Prévalence, Sérologie, Risque élevé, Développement maladie, Homme, Italie, Europe, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, HIV-1 virus, Human immunodeficiency virus, Lentivirinae, Retroviridae, Virus, Association, HTLV virus, Epidemiology, Prevalence, Serology, High risk, Disease development, Human, Italy, Europe, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0581105
Code Inist : 002B06D01. Création : 01/03/1996.